Schedule 13G ownership disclosure

Arcturus Therapeutics Ltd.

Security class unavailable · CUSIP: M1492T105

Event date: 2017-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000038777-17-000293
Form type
SC 13G/A
Filer
Arcturus Therapeutics Ltd.
CIK
CIK 1566049
Filed
Dec 11, 2017
Reporting period
Nov 30, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub